Category: Cancer Research

See recent blog posts and articles about cancer research at Massachusetts General Hospital.

macrophage

Mass General Researchers Investigate the ‘Big Eaters’ of the Immune System: #MacrophageMonday

Macrophages serve a vital function in the body’s immune system— these white blood cells are in charge of engulfing pathogens, foreign materials and dead cells. Two new studies from Massachusetts General Hospital researchers have identified two unexpected roles that macrophages play in the body. In the heart, macrophages play a beneficial role, helping heart muscle […]

Continue Reading
cropped-blog-banner-2000-x-1200.jpg

Celebrating the Role of Women in Science and Much More

Interested in the newest research studies and hot topics? Check out the latest issues of “From the Lab Bench”, a monthly newsletter from the Office of the Scientific Director at the Mass General Research Institute, and “Research Roundup”,  our monthly recap of the latest biomedical research news. In this month’s issue of From the Lab Bench, we […]

Continue Reading
63889039 - heap of round white tablets and plastic pills bottle

New Study Finds Low-Dose Aspirin May Lower Risk of Cancer Death

A new study from Massachusetts General Hospital reports that long-term regular aspirin was associated with a lower risk of dying from various types of cancers. Lead author, Yin Cao, MPH, ScD, a researcher in the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital, and her team studied the health outcomes of approximately 86,000 women and 44,000 […]

Continue Reading
cropped-blog-banner-2000-x-1200.jpg

Research Awards and Honors: March 2017

Massachusetts General Hospital’s talented and dedicated researchers are working to push the boundaries of science and medicine every day. In this series we highlight a few individuals who have recently received awards or honors for their achievements:  Ryan Corcoran, MD, PhD, of the Division of Hematology and Oncology, has been elected to the American Society for […]

Continue Reading
cropped-blog-banner-2000-x-1200.jpg

Specialized Screening Protocol May Improve Detection of Ovarian Cancer in High-Risk Women

First, let’s define a few key words: CA125: A protein found on the surface of many ovarian cancer cells. Most women with ovarian cancer have CA125 levels in the blood that are over 35. ROCA: An abbreviation for Risk of Ovarian Cancer Algorithm, a test that assesses risk for developing ovarian cancer. This test tracks […]

Continue Reading
cropped-blog-banner-2000-x-1200.jpg

Hormone May Protect and Preserve Ovaries During Chemotherapy

Chemotherapy’s anti-cancer effects depend on its ability to damage rapidly growing cells, which is beneficial when targeting cancer cells that multiply rapidly. However, chemotherapy also causes collateral damage to other types of rapidly growing cells, including cells found in the ovaries. A naturally occurring hormone that plays an important role in fetal development, called Mullerian […]

Continue Reading
cropped-blog-banner-2000-x-1200.jpg

Study Provides New Treatment Option For Recurring Prostate Cancer Patients

There is new hope for the more than 30 percent of prostate cancer patients who will experience cancer recurrence after undergoing surgery to remove their prostate gland. Prostate cancer cells need androgens (also known as male hormones) to grow, and, in order to function properly, androgens must bind to receptors in the prostate. Medications called […]

Continue Reading

BOTSOGO: Improving Cancer Care and Advancing Research in Botswana

By Milo Goodman Research Institute Communications Intern The Botswana Oncology Global Outreach (BOTSOGO) is a collaborative program between the Botswana-Harvard AIDS Institute Partnership (BHP) and Massachusetts General Hospital (MGH) that works to increase education about, access to, and quality of cancer care in Botswana. The program, which was established in 2011, was co-founded and is co-directed by Dr. Jason Efstathiou of […]

Continue Reading

Implantable Device Targets Pancreatic Cancer

A research team from Mass General and MIT has designed a tiny, adjustable implant that could be used to deliver chemotherapy drugs directly into pancreatic cancers, instead of requiring the drugs to travel through the entire circulatory system to reach the pancreas. In laboratory models, delivering treatment directly to the source proved to be 12 times more effective than intravenous […]

Continue Reading

Immunotherapy Effort Advances on Multiple Fronts

The Center for Cancer Immunology at Massachusetts General Hospital is focused on four major approaches to immunotherapy—checkpoint inhibitors, CAR T-cell therapy, vaccine therapy and early cancer immunotherapy.   LEARN MORE

Continue Reading